Figure 3
Comparing the extent of epileptogenic regions in responder (R) And non-responder (NR) patients. (A) Boxplots illustrate EZN extent determined by the number of EZN regions for R (in blue) and NR (in red) groups (respectively n = 10 and n = 13). (B) For PZN regions. (C) For epileptogenic and early propagation network regions (EPZN) (EZN + PZN). Each data point corresponds to the number of the specific brain regions considered for each patient (EZN, PZN and both). The black bar and black point represent the difference (but not significant pval = 0.053) between R and NR groups using the Wilcoxon test. ‘ns’ refers to a non-significant difference between the groups.

Comparing the extent of epileptogenic regions in responder (R) And non-responder (NR) patients. (A) Boxplots illustrate EZN extent determined by the number of EZN regions for R (in blue) and NR (in red) groups (respectively n = 10 and n = 13). (B) For PZN regions. (C) For epileptogenic and early propagation network regions (EPZN) (EZN + PZN). Each data point corresponds to the number of the specific brain regions considered for each patient (EZN, PZN and both). The black bar and black point represent the difference (but not significant pval = 0.053) between R and NR groups using the Wilcoxon test. ‘ns’ refers to a non-significant difference between the groups.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close